BIOMAT Database Logo BIOMAT Database Logo

Blood levels of insulin, glucagon and gastrin following intravenous and oral glucose administration in children with simple obesity. 1988

K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005755 Gastrins A family of gastrointestinal peptide hormones that excite the secretion of GASTRIC JUICE. They may also occur in the central nervous system where they are presumed to be neurotransmitters. Gastrin
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral

Related Publications

K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
[Blood insulin following oral glucose and L-phenylalanine administration in children with phenylketonuria].
December 1976, Pediatria polska,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
[Blood insulin levels during oral glucose administration in 43 obese children].
January 1969, Annales d'endocrinologie,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
PTHrP and insulin levels following oral glucose and calcium administration.
October 2006, European journal of internal medicine,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
[Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
September 1980, Polskie Archiwum Medycyny Wewnetrznej,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
Peptic ulcer and glucose homeostasis. I. Insulin, gastrin and glucagon responses to oral glucose and intravenous arginine in peptic ulcer patients.
July 1979, Nihon geka hokan. Archiv fur japanische Chirurgie,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
[Behavior of blood gastrin in humans after intravenous administration of thyrocalcitonin and glucagon].
November 1974, Bollettino della Societa italiana di biologia sperimentale,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
Fasting blood values of glucose, insulin, glucagon, gastrin following highly selective vagotomy in duodenal ulcer patients.
January 1980, European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
[Changes in blood insulin levels in obese children during fasting and after oral administration of glucose].
January 1984, Endokrynologia Polska,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
The effect of glucagon on the blood levels of gastrin, insulin and glucose in patients with gastric and duodenal ulcers.
October 1979, Acta hepato-gastroenterologica,
K Sztefko, and M Rybakowa, and Z Szafran, and P Sucharski, and E Sołtysik-Wilk, and W Jaworska
[Immunoreactive insulin and blood glucose levels following oral glucose load in patientss with dumping-syndrome].
April 1971, Klinische Wochenschrift,
Copied contents to your clipboard!